Literature DB >> 24200159

Collision of extensive exocrine and neuroendocrine neoplasms in multiple endocrine neoplasia type 1 revealed by cytogenetic analysis of loss of heterozygosity: a case report.

Koki Moriyoshi1, Sachiko Minamiguchi, Aya Miyagawa-Hayashino, Masakazu Fujimoto, Michiya Kawaguchi, Hironori Haga.   

Abstract

The combination of exocrine and neuroendocrine neoplasms is rarely found in the pancreas. These combined lesions vary from a clonal tumor with mixed differentiation to the incidental co-existence of two or more independent tumors, but the differential diagnosis is sometimes difficult. Here we report a case of multiple endocrine neoplasia type 1 (MEN1) with extensive ductal and neuroendocrine neoplastic changes. These two types of tumors admixed markedly in some parts, which made it difficult to determine the pathological diagnosis based on histological findings. Cytogenetic analysis showed that loss of heterozygosity (LOH) of the MEN1 locus exists in neuroendocrine but not in exocrine neoplasms, indicating that independent mechanisms of tumorigenesis may occur in these two types of tumors. This case shows the usefulness of cytogenetic analysis for the diagnosis of combined tumors of the pancreas. Extensive exocrine neoplastic change, including pancreatic intraepithelial neoplasia (PanIN) in virtually all pancreatic ducts and a focus of intraductal papillary mucinous neoplasm (IPMN) with focal invasion, was a distinguishing feature of the present case. The possible association of ductal tumorigenesis and a MEN1 background is discussed.
© 2013 The Authors. Pathology International © 2013 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  loss of heterozygosity; multiple endocrine neoplasia type 1; neuroendocrine tumors; pancreatic ductal carcinoma

Mesh:

Year:  2013        PMID: 24200159     DOI: 10.1111/pin.12088

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

1.  Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1.

Authors:  Akihisa Ohno; Nao Fujimori; Masami Miki; Takamasa Oono; Hisato Igarashi; Ryota Matsuda; Yutaka Koga; Yoshinao Oda; Takao Ohtsuka; Masafumi Nakamura; Tetsuhide Ito; Yoshihiro Ogawa
Journal:  Clin J Gastroenterol       Date:  2020-09-20

2.  Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor.

Authors:  Marco Schiavo Lena; Maria Giulia Cangi; Lorenza Pecciarini; Ilaria Francaviglia; Greta Grassini; Renaud Maire; Stefano Partelli; Massimo Falconi; Aurel Perren; Claudio Doglioni
Journal:  Virchows Arch       Date:  2020-10-01       Impact factor: 4.064

Review 3.  Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature.

Authors:  Simone Serafini; Gianfranco Da Dalt; Gioia Pozza; Stella Blandamura; Michele Valmasoni; Stefano Merigliano; Cosimo Sperti
Journal:  World J Surg Oncol       Date:  2017-05-02       Impact factor: 2.754

Review 4.  Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?

Authors:  Jingci Chen; Pengyan Wang; Ke Lv; Weixun Zhou
Journal:  Diagn Pathol       Date:  2021-11-20       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.